Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Evonik is building a new, highly flexible, global-scale production facility for pharmaceutical lipids in the United States. The new plant at Evonik’s Tippecanoe site in Lafayette, Indiana, will broadly position the Group for future growth in novel ...
read more
Thursday, September 28, 2023
Evonik is strengthening its platform of parenteral drug delivery solutions with three new standard PLA-PEG di-block copolymers and a new nanoparticle formulation service using sonication technology.
read more
Evonik has entered into a supply agreement with Cassava Sciences, a clinical-stage biotechnology company focused on neuroscience.
read more
Monday, September 10, 2018
Evoqua Water Technologies has completed an exclusive sales and distribution agreement with Horizon Solutions to expand local service in Puerto Rico.
read more
Evotec AG and Aptuit have entered into a definitive agreement under which Evotec will acquire Aptuit for $ 300 million.
read more
Evotec AG
(Frankfurt:EVT) (TecDAX) today announced that it has extended and expanded its medicinal chemistry collaboration with Active Biotech AB (NASDAQ OMX: ACTI), to further advance an existing programme, which has entered the lead optimisation ...
read more
Evotec AG has announced that in line with its strategy to participate in promising corporate formations it will deepen its already existing relationship with Carrick. Evotec will invest up to $ 6 m towards Carrick's latest funding round.
read more
Thursday, February 16, 2012
Evotec AG and IR Pharma today announced that they have entered into an exclusive strategic alliance to provide integrated drug discovery solutions to Pharmaceutical and Biotech companies in the field of Respiratory Diseases.
read more
Thursday, November 10, 2016
Evotec AG has announced a novel strategic partnership with the University of Oxford, Oxford University Innovation Ltd, OUI (the university's research commercialization company) and Oxford Sciences Innovation, OSI (the world's largest IP investment ...
read more
Evotec has announced a multi-year compound management agreement with Pierre Fabre Laboratories, the second largest private French pharmaceutical group.
read more
Evotec AG has announced a collaboration with UCB to provide a broad range of in vitro pharmacology services.
read more
Evotec AG announced it will make a strategic investment as part of Facio Therapies' 2017 funding round together with the Facioscapulohumeral dystrophy community.
read more
Evotec AG has announced a collaboration with Antibiotic Research UK to identify alternative means of treating infections that are resistant to currently available antibiotics.
read more
Evotec AG announced has successfully completed the acquisition of Aptuit as announced in detail on 30 July 2017.
read more
Evotec announced an integrated drug discovery collaboration with STORM Therapeutics to develop new small molecule epigenetic drugs for oncology and other therapeutic areas.
read more